Bookmark and Share

Erik C von Rosenvinge
 

Erik C von Rosenvinge M.D.

Academic Title: Assistant Professor
Primary Appointment: Medicine
Additional Title(s): Chief of Gastroenterology, VA Maryland Health Care System
evonrose@medicine.umaryland.edu
Location: UMMC, N3W62
Phone: (410) 328-7244
Fax: (410) 328-8315

Personal History:

Dr. von Rosenvinge graduated Phi Beta Kappa from the University of Maryland at College Park in 1995 with a degree in Biochemistry. He then attended the New York University School of Medicine, where he was elected to the Alpha Omega Alpha honor society. After graduating in 1999, he completed his residency training in Internal Medicine in a combined program at the David Grant USAF Medical Center, Travis AFB, California; and the UC Davis Medical Center in Sacramento, California.

Dr. von Rosenvinge served as a Staff Physician in the US Air Force from 2002 to 2006. During this time he also served as an Assistant Professor at the F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and was deployed twice in support of Operations Iraqi Freedom and Enduring Freedom, earning him numerous military honors. After finishing his military service, Dr. von Rosenvinge completed his fellowship training in Gastroenterology & Hepatology at the University of Maryland School of Medicine, Baltimore, and the National Institutes of Health, Bethesda, Maryland. Dr. von Rosenvinge joined the faculty of the University of Maryland School of Medicine and Baltimore VA Medical Center in July 2009.

Research Interests:

Enteric infections, Clostridium difficile, gastrointestinal microbiome, the role of GI peptides in malignancy

Clinical Speciality:

Gastroenterology & Hepatology


Publications:

Ji X, von Rosenvinge EC, Johnson WW, Tomarev SI, Piatigorsky J, Armstrong RN, Gilliland GL. Three-dimensional structure, catalytic properties, and evolution of a sigma class glutathione transferase from squid, a progenitor of the lens S-crystallins of cephalopods. Biochemistry. 1995 Apr 25;34(16):5317-28.

Ji X, von Rosenvinge EC, Johnson WW, Armstrong RN, Gilliland GL. Location of a potential transport binding site in a sigma class glutathione transferase by x-ray crystallography. Proceedings of the National Academy of Sciences. 1996 Aug 6;93(16):8208-13.

Lin B, Malanoski AP, Wang Z, Blaney KM, Ligler AG, Rowley RK, Hanson EH, von Rosenvinge E, Ligler FS, Kusterbeck AW, Metzgar D, Barrozo CP, Russell KL, Tibbetts C, Schnur JM, Stenger DA. Application of broad-spectrum, sequence-based pathogen identification in an urban population. PLOS ONE. 2007 May 9;2(5):e419.

von Rosenvinge EC, Koh C, Rotman Y, Lim RM. Gastrointestinal malignant melanoma. Gastroenterology. 2008 Jul;135(1):e5-e6.

von Rosenvinge EC, Forman JS, Goldberg EM. Amyloidomas of the small bowel.  Gastroenterology. 2008 Sep;135(3):e1-2.

Yao MD, von Rosenvinge EC, Groden C, Mannon P. Multiple endoscopic biopsies in research subjects: safety results from an NIH series. Gastrointestinal Endoscopy. 2009 Apr;69(4):906-10. 

von Rosenvinge EC, Wank SA, Lim RM. Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome. Gastroenterology. 2009 Oct;137(4):1222,537.

von Rosenvinge EC, Gopal LD, Heller T, Kohn EC, Yao MD. Rectal fistulae resulting from treatment with sorafenib and bevacizumab. Gastrointestinal Endoscopy. 2009 Dec;70(6):1246-7.

von Rosenvinge EC, O’Donnell TG, Holland SM, Heller T. Chronic granulomatous disease. Inflammatory Bowel Diseases. 2010 Jan;16(1):9.

von Rosenvinge EC & Raufman JP. Gastrointestinal peptides and regulation of gastric acid secretion. Current Opinion in Endocrinology, Diabetes & Obesity. 2010 Feb;17(1):40-43.

von Rosenvinge EC, Koh C, Holland SM, Heller T. When to leave a stone unturned . . . Gut. 2010 Aug;59(8):1036,1100

von Rosenvinge EC & Raufman JP. Muscarinic signaling in colon cancer. Cancers. 2011 Mar;3(1),971-81.

von Rosenvinge EC, O’May GA, Macfarlane S, Macfarlane GT, Shirtliff ME. Microbial biofilms and gastrointestinal diseases. Pathogens and Disease. 2013 Feb;67(1),25-38.

Cullen NR, Yfantis HG, von Rosenvinge EC. "Stalk"ing the etiology of rectal bleeding. Gastroenterology. 2013 Jun;144(7):1355,1578.

von Rosenvinge EC, Sang Y, White JR, Maddox C, Blanchard T, Fricke WF. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME Journal. 2013 Jul;7(7):1354-66.

Curtin B, von Rosenvinge EC. A problematic polyp. Gastroenterology. 2013 Oct;145(4),e3-4.

von Rosenvinge EC, Cheng K, Drachenberg CB, Fowler CB, Evers DL, Xie G, Raufman JP. Bedside to bench: Role of muscarinic receptor activation in ultrarapid growth of colorectal cancer in a patient with pheochromocytoma. Mayo Clinic Proceedings. 2013 Nov;88(11):1340-46.

Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLOS ONE. 2013 Nov;8(11):e81330.

Curtin BF, Zarbalian Y, Flasar MH, von Rosenvinge EC. Clostridium difficile-associated disease: Adherence with current guidelines at a tertiary medical center. World Journal of Gastroenterology. 2013 Dec 14;19(46):8647-8651.

Piepenbrink KH, Maldarelli GA, Martinez de la Pena CF, Mulvey GL, Snyder GA, De Masi L, von Rosenvinge EC, Guenther S, Armstrong GD, Donnenberg MS, Sundberg EJ. Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known Type IV pilins. The Journal of Biological Chemistry. 2013. Dec 21. [Epub ahead of print].